| NCT ID | NCT07172880 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kara Whitaker |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2023-07-01 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2023-07-01 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is growing evidence that maternal health and behaviors in pregnancy, such as pre-pregnancy obesity, excessive gestational weight gain, poor diet, smoking, and adverse pregnancy outcomes, are linked to fetal programming for obesity and cardiovascular disease (CVD) risk in the offspring. Yet, there is a surprising lack of research on the role of prenatal sedentary behavior, physical activity, and sleep (conceptualized together as 24-hour behavior) on offspring obesity risk and CVD risk; this is an unfortunate research gap since there is strong physiological rationale that these behaviors in pregnancy could influence offspring health and are modifiable intervention targets in pregnancy. This multi-site observational cohort study will leverage state-of-the-art, 24-hour behavior assessment in each trimester of pregnancy, collected as part of the Pregnancy 24/7 cohort study and add additional assessments of offspring growth, adiposity, and CVD risk through 24 months to inform future primordial prevention interventions to decrease the risk of offspring obesity and CVD across the lifespan.
Eligibility Criteria
Maternal Inclusion Criteria: * Enrolled in Pregnancy 24/7 Study. * Completed at least one 24-hr behavior assessment, with valid objective activity monitor data and questionnaires. * Pregnancy resulted in singleton live birth. Offspring Exclusion Criteria: -Child diagnosed with congenital or chromosomal abnormalities that may affect growth or CVD risk.
Contact & Investigator
Kara M Whitaker, PhD, MPH
PRINCIPAL INVESTIGATOR
University of Iowa
Frequently Asked Questions
Who can join the NCT07172880 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 47 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07172880 currently recruiting?
Yes, NCT07172880 is actively recruiting participants. Contact the research team at kara-whitaker@uiowa.edu for enrollment information.
Where is the NCT07172880 trial being conducted?
This trial is being conducted at Iowa City, United States, Pittsburgh, United States, Morgantown, United States.
Who is sponsoring the NCT07172880 clinical trial?
NCT07172880 is sponsored by Kara Whitaker. The principal investigator is Kara M Whitaker, PhD, MPH at University of Iowa. The trial plans to enroll 800 participants.